Korean College of Rheumatology Biologics and Targeted Therapy Registry
Recruiting · NCT01965132 · Observational (researchers observe without assigning treatment) · Lead sponsor: Seoul National University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Biologic or targeted synthetic DMARD
What this trial is about
We established a nationwide biologics and targeted synthetic DMARDs registry (in the form of an inception cohort) to study the safety profiles in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients receiving biologics or targeted synthetic DMARDs. As this registry is to observe the "real world" use of anti-rheumatic treatments under routine clinical practice, no hypothesis to prove is planned.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients diagnosed with RA, AS or PsA
- RA deemed by their rheumatologist to require treatment with a biologic or targeted synthetic DMARDs or a conventional DMARD(s)
- AS or PsA patients who are to initiate, restart or switch to a biologic agent or a targeted synthetic DMARD
- Patients who provide a written consent of participating in this registry (data collection and review).
Exclusion criteria
- RA, AS, PsA patients who are already on biologics or targeted synthetic DMARDs upon screening
Where it is running
2 locations listed.
- Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, South Korea
- Seoul Metropolitan Government-Seoul National University Boramae Medical Center - Seoul, South Korea